世界の分子インフルエンザ検査市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP13411)
◆英語タイトル:Global Molecular Influenza Test Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP13411
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月25日(※2024年版があります。お問い合わせください。)
◆ページ数:103
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、分子インフルエンザ検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。分子インフルエンザ検査の種類別市場規模(RT-PCR、TMA、LAMP、NASBA、その他)、用途別市場規模(病院、臨床検査室、その他のエンドユーザー)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):F. Hoffmann-La Roche、Abbott Laboratories、Quidel Corporation、bioMérieux、Thermo Fisher Scientific、DiaSorin、Becton, Dickinson, and Company
・地域別グローバル市場分析 2015年-2020年
・分子インフルエンザ検査の北米市場(アメリカ、カナダ、メキシコ)
・分子インフルエンザ検査のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・分子インフルエンザ検査のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・分子インフルエンザ検査の南米市場(ブラジル、アルゼンチン)
・分子インフルエンザ検査の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:RT-PCR、TMA、LAMP、NASBA、その他
・用途別分析:病院、臨床検査室、その他のエンドユーザー
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The Molecular Influenza Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Molecular Influenza Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Molecular Influenza Test market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Molecular Influenza Test market has been segmented into:
RT-PCR
TMA
LAMP
NASBA
Other

By Application, Molecular Influenza Test has been segmented into:
Hospitals
Clinical Laboratories
Other End-User

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Molecular Influenza Test market presented in the report. This section sheds light on the sales growth of different regional and country-level Molecular Influenza Test markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Molecular Influenza Test market.

The report offers in-depth assessment of the growth and other aspects of the Molecular Influenza Test market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Molecular Influenza Test Market Share Analysis
Molecular Influenza Test competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Molecular Influenza Test sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Molecular Influenza Test sales, revenue and market share for each player covered in this report.

The major players covered in Molecular Influenza Test are:
F. Hoffmann-La Roche
Abbott Laboratories
Quidel Corporation
bioMérieux
Thermo Fisher Scientific
DiaSorin
Becton, Dickinson, and Company
Among other players domestic and global, Molecular Influenza Test market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

【レポートの目次】

1 Molecular Influenza Test Market Overview
1.1 Product Overview and Scope of Molecular Influenza Test
1.2 Classification of Molecular Influenza Test by Type
1.2.1 Global Molecular Influenza Test Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Molecular Influenza Test Revenue Market Share by Type in 2019
1.2.3 RT-PCR
1.2.4 TMA
1.2.5 LAMP
1.2.6 NASBA
1.2.7 Other
1.3 Global Molecular Influenza Test Market by Application
1.3.1 Overview: Global Molecular Influenza Test Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Other End-User
1.4 Global Molecular Influenza Test Market by Regions
1.4.1 Global Molecular Influenza Test Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Molecular Influenza Test (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Molecular Influenza Test Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Molecular Influenza Test Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Molecular Influenza Test Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Molecular Influenza Test Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Molecular Influenza Test Status and Prospect (2015-2025)
2 Company Profiles
2.1 F. Hoffmann-La Roche
2.1.1 F. Hoffmann-La Roche Details
2.1.2 F. Hoffmann-La Roche Major Business
2.1.3 F. Hoffmann-La Roche SWOT Analysis
2.1.4 F. Hoffmann-La Roche Product and Services
2.1.5 F. Hoffmann-La Roche Molecular Influenza Test Revenue, Gross Margin and Market Share (2018-2019)
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories SWOT Analysis
2.2.4 Abbott Laboratories Product and Services
2.2.5 Abbott Laboratories Molecular Influenza Test Revenue, Gross Margin and Market Share (2018-2019)
2.3 Quidel Corporation
2.3.1 Quidel Corporation Details
2.3.2 Quidel Corporation Major Business
2.3.3 Quidel Corporation SWOT Analysis
2.3.4 Quidel Corporation Product and Services
2.3.5 Quidel Corporation Molecular Influenza Test Revenue, Gross Margin and Market Share (2018-2019)
2.4 bioMérieux
2.4.1 bioMérieux Details
2.4.2 bioMérieux Major Business
2.4.3 bioMérieux SWOT Analysis
2.4.4 bioMérieux Product and Services
2.4.5 bioMérieux Molecular Influenza Test Revenue, Gross Margin and Market Share (2018-2019)
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific SWOT Analysis
2.5.4 Thermo Fisher Scientific Product and Services
2.5.5 Thermo Fisher Scientific Molecular Influenza Test Revenue, Gross Margin and Market Share (2018-2019)
2.6 DiaSorin
2.6.1 DiaSorin Details
2.6.2 DiaSorin Major Business
2.6.3 DiaSorin Product and Services
2.6.4 DiaSorin Molecular Influenza Test Revenue, Gross Margin and Market Share (2018-2019)
2.7 Becton, Dickinson, and Company
2.7.1 Becton, Dickinson, and Company Details
2.7.2 Becton, Dickinson, and Company Major Business
2.7.3 Becton, Dickinson, and Company Product and Services
2.7.4 Becton, Dickinson, and Company Molecular Influenza Test Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Molecular Influenza Test Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Molecular Influenza Test Players Market Share
3.2.2 Top 10 Molecular Influenza Test Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Molecular Influenza Test Revenue and Market Share by Regions
4.2 North America Molecular Influenza Test Revenue and Growth Rate (2015-2020)
4.3 Europe Molecular Influenza Test Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Molecular Influenza Test Revenue and Growth Rate (2015-2020)
4.5 South America Molecular Influenza Test Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Molecular Influenza Test Revenue and Growth Rate (2015-2020)
5 North America Molecular Influenza Test Revenue by Countries
5.1 North America Molecular Influenza Test Revenue by Countries (2015-2020)
5.2 USA Molecular Influenza Test Revenue and Growth Rate (2015-2020)
5.3 Canada Molecular Influenza Test Revenue and Growth Rate (2015-2020)
5.4 Mexico Molecular Influenza Test Revenue and Growth Rate (2015-2020)
6 Europe Molecular Influenza Test Revenue by Countries
6.1 Europe Molecular Influenza Test Revenue by Countries (2015-2020)
6.2 Germany Molecular Influenza Test Revenue and Growth Rate (2015-2020)
6.3 UK Molecular Influenza Test Revenue and Growth Rate (2015-2020)
6.4 France Molecular Influenza Test Revenue and Growth Rate (2015-2020)
6.5 Russia Molecular Influenza Test Revenue and Growth Rate (2015-2020)
6.6 Italy Molecular Influenza Test Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Molecular Influenza Test Revenue by Countries
7.1 Asia-Pacific Molecular Influenza Test Revenue by Countries (2015-2020)
7.2 China Molecular Influenza Test Revenue and Growth Rate (2015-2020)
7.3 Japan Molecular Influenza Test Revenue and Growth Rate (2015-2020)
7.4 Korea Molecular Influenza Test Revenue and Growth Rate (2015-2020)
7.5 India Molecular Influenza Test Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Molecular Influenza Test Revenue and Growth Rate (2015-2020)
8 South America Molecular Influenza Test Revenue by Countries
8.1 South America Molecular Influenza Test Revenue by Countries (2015-2020)
8.2 Brazil Molecular Influenza Test Revenue and Growth Rate (2015-2020)
8.3 Argentina Molecular Influenza Test Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Molecular Influenza Test by Countries
9.1 Middle East & Africa Molecular Influenza Test Revenue by Countries (2015-2020)
9.2 Saudi Arabia Molecular Influenza Test Revenue and Growth Rate (2015-2020)
9.3 UAE Molecular Influenza Test Revenue and Growth Rate (2015-2020)
9.4 Egypt Molecular Influenza Test Revenue and Growth Rate (2015-2020)
9.5 South Africa Molecular Influenza Test Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Molecular Influenza Test Revenue and Market Share by Type (2015-2020)
10.2 Global Molecular Influenza Test Market Forecast by Type (2019-2024)
10.3 RT-PCR Revenue Growth Rate (2015-2025)
10.4 TMA Revenue Growth Rate (2015-2025)
10.5 LAMP Revenue Growth Rate (2015-2025)
10.6 NASBA Revenue Growth Rate (2015-2025)
10.7 Other Revenue Growth Rate (2015-2025)
11 Global Molecular Influenza Test Market Segment by Application
11.1 Global Molecular Influenza Test Revenue Market Share by Application (2015-2020)
11.2 Molecular Influenza Test Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinical Laboratories Revenue Growth (2015-2020)
11.5 Other End-User Revenue Growth (2015-2020)
12 Global Molecular Influenza Test Market Size Forecast (2021-2025)
12.1 Global Molecular Influenza Test Market Size Forecast (2021-2025)
12.2 Global Molecular Influenza Test Market Forecast by Regions (2021-2025)
12.3 North America Molecular Influenza Test Revenue Market Forecast (2021-2025)
12.4 Europe Molecular Influenza Test Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Molecular Influenza Test Revenue Market Forecast (2021-2025)
12.6 South America Molecular Influenza Test Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Molecular Influenza Test Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【掲載企業】

F. Hoffmann-La Roche、Abbott Laboratories、Quidel Corporation、bioMérieux、Thermo Fisher Scientific、DiaSorin、Becton, Dickinson, and Company

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の分子インフルエンザ検査市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Molecular Influenza Test Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。